Siroda is the trade name of capecitabine, which is mainly used in postoperative chemotherapy and preoperative conversion therapy for colon or rectal malignancies, and is a common oral chemotherapy drug. At present, a box of Xyroda costs about 300-400 yuan, and the price of Xyroda varies from hospital to hospital, mainly due to the different bidding prices of the drug. In addition, most of the provinces have already included Xyroda into the scope of medical insurance reimbursement, so the out-of-pocket cost for buying Xyroda is mainly determined by the medical insurance related policies formulated by the local medical insurance department. In addition, for chemotherapy of malignant tumors, some provinces have also formulated relevant drug subsidies and disease relief policies. All in all, although the price of Xyroda is between 300-400 RMB, after reimbursement by medical insurance and government subsidies, the out-of-pocket expenses may only be about 100-200 RMB.